Gaining weight after stopping Wegovy: what to expect and what to do

Weight regain after stopping Wegovy is common and is driven by hormonal changes, not lifestyle failure — appetite signals that the medicine suppressed tend to return.
Clinical trial data show that participants who stopped semaglutide regained the majority of lost weight within a year of stopping, on average.
The decision to stop, pause, or switch is a clinical one; your prescriber can help you plan a structured exit or transition to an alternative.
Ongoing lifestyle changes (protein-adequate eating, regular physical activity, behavioural support) reduce but rarely eliminate regain without medication.

Most people do regain some weight after stopping Wegovy. Clinical evidence suggests that, without the medicine, appetite and hunger hormones return toward their pre-treatment baseline — and for many people, so does the weight. This is not a failure of effort or willpower; it reflects how the biology of weight regulation actually works. Wegovy (semaglutide) is a prescription-only medicine, and any decision about stopping, continuing, or switching treatment should be made with a prescriber who can look at your full clinical picture. If you're thinking through that decision now, the sections below cover what the science says, what your options are, and how to approach it sensibly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding regain, managing the decision, and what comes next

Why weight comes back when semaglutide stops

Semaglutide works by activating GLP-1 receptors that slow gastric emptying, reduce appetite and improve satiety signals. While you're taking it, the medicine is doing a significant amount of physiological work. Stop taking it, and that work stops too. Hunger hormones, including ghrelin, tend to rise back toward levels the body was producing before treatment began. Energy intake often creeps up; weight follows.

The STEP 1 extension study is the clearest evidence base here. Participants who completed 68 weeks of semaglutide 2.4mg treatment and then entered a 52-week placebo phase regained, on average, around two-thirds of the weight they had lost, without any changes in the lifestyle support they received. The STEP 1 trial, published in the New England Journal of Medicine, documented an average of roughly 15% body-weight reduction during active treatment; post-discontinuation, the gap between the treated and placebo groups narrowed substantially within twelve months.

This pattern is consistent across GLP-1 medicines. It does not mean treatment failed; it means weight is a chronic condition, not one that resolves after a course of tablets. Many conditions require long-term management, and obesity is increasingly understood in the same clinical frame. Understanding this is the starting point for making a genuinely informed decision about what to do next, rather than reacting to the number on the scales.

The factors that shape how much weight returns

Regain is not uniform. Some people hold on to more of their progress than others, and the factors involved are worth understanding before you make any decision. How long you were on treatment matters: people who had more time to embed new eating habits and build activity levels alongside their medication tend to have a better foundation. The dose at which you stopped is relevant too, someone who never titrated beyond 1mg will have had a different appetite-suppression experience from someone who reached 2.4mg maintenance.

Metabolic factors play a role. If you have type 2 diabetes or insulin resistance, the hormonal picture after stopping is different from someone who was otherwise metabolically healthy. Your starting weight also shapes the absolute amount of regain: a larger initial loss gives more room for partial regain while still sitting below your pre-treatment weight.

Lifestyle changes embedded during treatment can slow regain, though trial data consistently show they don't prevent the majority of it. Protein intake, resistance exercise and keeping refined carbohydrate low all support the body's satiety signals, which are working harder without semaglutide. These are worth sustaining regardless of what you decide about medication. You might also want to read more about the relationship between stopping Wegovy and weight gain, which goes into the hormonal mechanics in more detail.

Framing the actual decision in front of you

Most people reading this are facing one of a small number of situations: you've stopped Wegovy, noticed the scales moving upward, and want to understand what's happening; you're considering stopping and want to know what to expect; or you're wondering whether switching to a different medicine might give you a different outcome. Each of these is a different clinical question, and none has a single right answer.

If you've already stopped and regain has started, the first thing worth knowing is that early regain is often more rapid than later regain, it tends to slow. Re-starting semaglutide, if clinically appropriate, can reverse it, and our page on gaining weight after Wegovy explains what typically drives that rebound and what your options are. Switching to tirzepatide (Mounjaro), a dual GIP and GLP-1 receptor agonist, is an option some people explore; our semaglutide overview page covers how semaglutide compares to other licensed medicines for weight management in the UK.

If you're thinking about stopping intentionally, it's worth having a structured conversation with your prescriber before you do, rather than after regain has happened. Our page on stopping Wegovy after weight loss walks through what a planned approach looks like, including how to think about monitoring and when it might make sense to return to treatment. There's no rule that says once you're off treatment you can't go back on it, but the decision is yours to make with clinical support, not alone.

Some people wonder whether cost is driving their thinking. Understanding where to source Wegovy through legitimate, clinically supervised routes is important context if that's part of your picture. A private prescription for a licensed medicine should always come with clinical oversight, not just a dispensed pen.

What a prescriber can actually offer at this point

A GPhC-registered prescriber reviewing your situation can do several things a general search cannot: look at your weight trajectory, your current BMI and any comorbidities, the dose you were on, and how long you've been off treatment. From that, they can discuss re-starting semaglutide, consider whether tirzepatide might be more appropriate for you, or help you build a realistic plan for managing without medication for now.

At nume, a real clinician (not an automated screening tool) reviews every consultation. If you order before 12pm on a working day and are clinically approved, treatment can be dispatched the same day with free tracked delivery the next working day. The FAQs on our site cover what the consultation involves for people who've previously been on treatment and are considering returning. For anyone revisiting this question after a gap, what typically happens in the period after stopping Wegovy is a useful starting point.

The NHS semaglutide medicines page also has clear, plain-language information on what the medicine does and why stopping it changes things, written for patients. It's a good companion resource alongside a clinical conversation.

If you'd like to talk through your options with a prescriber, you can start your free consultation here. There's no obligation, and a clinician will review your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions